BMS-986504 drug page Clinical trials

Trials with BMS-986504

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
2Recruiting
14Countries
268Planned patients

Showing 1–2 of 2

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Recruiting Phase 2 260 patients NCT07492680

This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in participants with advanced and/or metastatic solid tumors that have MTAP deletion. The study includes a monotherapy component and a combination component in which BM…

United States, Belgium, Canada, China and 8 more Jul 2026 – May 2032 Interventional
A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
Recruiting Phase 1 8 patients NCT06672523

The purpose of this study is to evaluate the mass balance, metabolism, elimination, and drug levels of \[14C\]-BMS-986504 (MRTX1719) in participants with advanced solid tumors with homozygous methylthioadenosine phosphorylase deletion.

Hungary, Spain Mar 2025 – Oct 2027 Interventional

Where the recruiting trials are